NanoRepro AG
XETRA:NN6
NanoRepro AG
Cost of Revenue
NanoRepro AG
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NanoRepro AG
XETRA:NN6
|
Cost of Revenue
-€106.1m
|
CAGR 3-Years
-433%
|
CAGR 5-Years
-170%
|
CAGR 10-Years
N/A
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Cost of Revenue
-€893.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Cost of Revenue
-€129.7m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
Siemens Healthineers AG
XETRA:SHL
|
Cost of Revenue
-€14B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Cost of Revenue
-€1.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
Sartorius AG
XETRA:SRT
|
Cost of Revenue
-€1.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-16%
|
See Also
What is NanoRepro AG's Cost of Revenue?
Cost of Revenue
-106.1m
EUR
Based on the financial report for Dec 31, 2021, NanoRepro AG's Cost of Revenue amounts to -106.1m EUR.
What is NanoRepro AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-170%
Over the last year, the Cost of Revenue growth was -1 042%. The average annual Cost of Revenue growth rates for NanoRepro AG have been -433% over the past three years , -170% over the past five years .